{"disease":{"id":"relapsed-refractory-acute-myeloid-leukemia-and-chronic-granulocytic-mononocytic-leukemia","name":"relapsed refractory acute myeloid leukemia and chronic granulocytic mononocytic leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05548088","title":"LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Peking University People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}